Works matching IS 10073639 AND DT 2022 AND VI 32 AND IP 12

Results: 13

脑胶质瘤干细胞衍生的外泌体lncRNA HOXAAS2 促进脑胶质瘤的增殖、迁移、侵袭和干细胞特性.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1218, doi. 10.19401/j.cnki.1007-3639.2022.12.010

By:

廖星合;
刘占涛;
刘明辉

Publication type:

Article

CPCC晚期前列腺癌中国专家共识——转移性激素敏感性前列腺癌起始应用新型内分泌治疗的全程管理（2022年版).

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1242, doi. 10.19401/j.cnki.1007-3639.2022.12.013

By:

叶定伟;
黄健

Publication type:

Article

固有免疫细胞上Siglec在肿瘤中作用的研究进展与展望.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1235, doi. 10.19401/j.cnki.1007-3639.2022.12.012

By:

郭朝阳;
胡镜宙

Publication type:

Article

神经侵犯在新辅助放疗后ypⅠ~Ⅱ期直肠癌中的预后预测价值.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1229, doi. 10.19401/j.cnki.1007-3639.2022.12.011

By:

王俊;
何平

Publication type:

Article

构建并验证nomogram模型预测ⅠA期肺腺癌肺泡间转移.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1210, doi. 10.19401/j.cnki.1007-3639.2022.12.009

By:

张龙富;
刘洁;
倪筝;
路新源;
胡斌;
汪灏;
冯明祥;
张勇

Publication type:

Article

干预自噬影响DPD的表达促进5-FU抗结直肠癌疗效的实验研究.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1199, doi. 10.19401/j.cnki.1007-3639.2022.12.008

By:

崔忠泽;
何双;
温菲菲;
李扬扬;
许晓阳;
路丽祯;
吴淑华

Publication type:

Article

MMR蛋白在515例子宫内膜样腺癌中表达及其与临床病理学特征的相关性分析.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1190, doi. 10.19401/j.cnki.1007-3639.2022.12.007

By:

武全;
郭静伟;
雷雨馨;
胡晓儒;
王哲

Publication type:

Article

口腔黏膜恶性黑色素瘤肺转移特征及预后分析.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1184, doi. 10.19401/j.cnki.1007-3639.2022.12.006

By:

韩如雪;
梁翔;
马旭辉;
郭伟;
吴云腾;
任国欣

Publication type:

Article

达拉非尼联合曲美替尼用于24例恶性黑色素瘤辅助治疗的回顾性分析.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1178, doi. 10.19401/j.cnki.1007-3639.2022.12.005

By:

贾东东;
李涛

Publication type:

Article

前哨淋巴结活检在皮肤型和肢端型黑色素瘤临床诊疗中的价值.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1168, doi. 10.19401/j.cnki.1007-3639.2022.12.004

By:

邹孜瑊;
孙伟;
胡涂;
王春萌;
严望军;
罗志国;
刘欣;
钟景钦;
林馨怡;
徐宇;
陈勇

Publication type:

Article

近5年单中心肢端型及皮肤型黑色素瘤外科治疗患者的预后因素分析.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1158, doi. 10.19401/j.cnki.1007-3639.2022.12.003

By:

林馨怡;
孙伟;
胡涂;
王春萌;
严望军;
罗志国;
刘欣;
钟景钦;
邹孜瑊;
徐宇;
陈勇

Publication type:

Article

III 期恶性黑色素瘤患者术后辅助抗PD-1 vs 靶向治疗：中国多中心真实世界数据分.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1147, doi. 10.19401/j.cnki.1007-3639.2022.12.002

By:

李婷;
徐宇;
贾东东;
廖智超;
孙伟;
吴海啸;
任志午;
赵军;
邢汝维;
滕胜;
杨蕴;
陈勇;
李涛;
杨吉龙

Publication type:

Article

I期黑色素瘤围手术期治疗的现状与展望.

Published in:

China Oncology, 2022, v. 32, n. 12, p. 1133, doi. 10.19401/j.cnki.1007-3639.2022.12.001

By:

徐宇;
陈勇;
杨吉龙;
朱冠男

Publication type:

Article